Global Leaders in Geroscience Convene for Biomarkers of Aging

The Biomarkers of Aging Consortium will host its fourth annual Biomarkers of Aging Conference on October 5 and 6, 2026, at the Joseph B. Martin Conference Center at Harvard Medical School. The meeting brings together academic, clinical, industry, regulatory, and philanthropic leaders working to develop, validate, and apply biomarkers of aging.

Therapies that target aging itself are approaching the clinic. Their progress depends on reliable, standardized ways to measure biological aging and to show whether an intervention changes it. The conference is built around closing that gap.

Program Highlights

The 2026 program features nearly 30 speakers from leading universities, research institutes, companies, and funding and regulatory agencies. Invited speakers include:

• Epigenetic clocks and pace of aging: Steve Horvath (UCLA), developer of the first pan-tissue epigenetic clock, and Dan Belsky (Columbia University), coinventor of the DunedinPACE clock
• Quantitative and systems views of aging: Uri Alon (Weizmann Institute of Science), Albert-László Barabási (Northeastern University), and Michael Levin (Tufts University), bringing mathematical, network medicine, and bioelectric perspectives Mechanisms of aging and longevity: Vera Gorbunova (University of Rochester), Thomas Rando (UCLA), and Mike Snyder (Stanford), spanning exceptionally long-lived species, stem cell aging, and longitudinal multi-omic profiling of people
• AI and causal biology in industry: Morgan Levine (stealth-stage company) and Martin Borch Jensen (Gordian Biotechnology), building AI models of biology and causal atlases of age-related disease
• Funding, regulation, and translation: Andrew Brack (ARPA-H), Cynthia Grossman (U.S. Food and Drug Administration), Jamie Justice (XPRIZE Healthspan), and Lynne Cox (Wellcome Leap), speaking to how aging biomarkers move toward trials and approved endpoints

Sessions span novel biomarker discovery, multi-omic and AI-based approaches, immune and cellular aging, and the use of biomarkers to evaluate longevity interventions. Selected poster presenters will give short talks, and an expert jury will award poster prizes.

The conference is cochaired by Vadim Gladyshev, Chiara Herzog, Andrea Cipriano, Jesse Poganik, and Mahdi Moqri The full program is available here.

From the Conference Chairs

“The field of aging biomarkers is constantly evolving and growing, and this is our most diverse year yet. We’re excited to bring experts and stakeholders in areas such as molecular screening to population science and the ethics of longevity together – across academia, biotech, pharma and policy,” said Chiara Herzog, Ph.D., conference co-chair, executive committee member, and Assistant Professor at the University of Cambridge.

“The science of measuring aging has moved remarkably fast, but speed is not the same as trust,” said Jesse Poganik, Ph.D., conference co-chair, co-director of the Biomarkers of Aging Consortium, and Investigator at Brigham and Women’s Hospital and Harvard Medical School. “Before an aging biomarker can guide a clinical trial or a treatment decision, the field needs to agree on how it is validated and what it actually tells us. This meeting puts the people building these tools in the same room as the people who fund, regulate, and depend on them.”

New for 2026: Satellite Programs

The conference anchors a week of related programming at Harvard Medical School. A full-day Replacement in Aging Session, focused on replacement and regenerative strategies, runs as part of the conference, and conference tickets also include access to the Gerophysics Session. On October 7, the Consortium will co-host two satellite symposia in the Pechet Room of the Joseph B. Martin Conference Center: the Brain Aging Symposium from 8:00 am to 2:00 pm, followed by the Reproductive Aging Symposium from 2:00 pm to 6:30 pm.

About the Biomarkers of Aging Consortium

The Biomarkers of Aging Consortium is a collaborative initiative spanning more than 50 institutions. It supports the global geroscience community by developing standardized, clinically validated ways to measure aging and assess the outcomes of interventions. Its programs include the Biolearn open-source platform, the Biomarkers of Aging Challenge, The Longevity Study, and an annual conference. The Consortium is fiscally sponsored by the Methuselah Foundation.

Media Contact

Jesse Poganik, Biomarkers of Aging Consortium: community@agingconsortium.org